---
layout: archive
title: "Work in Progress"
permalink: /workinprogress/
author_profile: true

---

## Understanding sources of inefficiency in health care

- **A Hard Look at ‘Soft’ Cost‐control Measures in Healthcare Organizations: Evidence from Preferred Drug Policies in Germany.** with Daniel Avdic, [CINCH working paper series 2021(08). doi: 10.17185/duepublico/74978.](https://duepublico2.uni-due.dereceive/duepublico_mods_00074978)
  [An earlier version was nomiated as 10% best submissions to Health Care Management Division of the Academy of Management 2021](https://ideas.repec.org/p/ajt/wcinch/74978.html).
  
- [Rantsi M, **Blankart K**, Lauri K, Johanna J, Virva HH. Not in Isolation: How Physician Networks Influence Evidence-Based Prescribing of Psychotropics to Older People with Dementia [Internet]. Rochester, NY; 2024 26](https://papers.ssrn.com/abstract=4959345)


## Innovators & innovation policy in health care

- **Does access to quality accreditation improve health? - Patient-level evidence from German cancer care**, with Tim Brand
- **The Local Influence of Knowledge Production, Pioneers, and Star Researchers on Technology Adoption - Evidence from Cardiovascular Medical Technology**, with Meilin Möllenkamp and Jonas Schreyögg.


- - -


## Regulation and market design of pharmaceutical and biotechnological markets

- **The Multidimensional Nature of Medicine Shortages: A Network of Causes for Evidence-Based Intervention Development**, with Panhuysen J, Goetjes E, Shaikh M
- **Medicine Shortages, Global Dependency, and Competition in Times of a Pandemic – a Regression  Discontinuity in Time Approach**, with Panhuysen J, Goetjes E, Shaikh M
- **The consequences of medicine shortages on healthcare utilization and fragmentation of care**, with Panhuysen J, Goetjes E, Shaikh M


## Deceased papers

- [**Stakeholder Participation in Regulatory Decision-Making**, with Victoria Lauenroth and Tom Stargardt](https://journals.aom.org/doi/10.5465/AMBPP.2018.11748abstract).


- - -



